Corbus Pharmaceuticals Holdings (CRBP) EBT Growth (1y) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EBT Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.34% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -51.60% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -313.33% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -79.57% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 71.54% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -26.08% |
| Jun 30, 2025 | -2,120.25% |
| Mar 31, 2025 | -10,562.96% |
| Dec 31, 2024 | 116.13% |
| Sep 30, 2024 | 114.54% |
| Jun 30, 2024 | 110.32% |
| Mar 31, 2024 | 101.09% |
| Dec 31, 2023 | -2.20% |
| Sep 30, 2023 | -27.95% |
| Jun 30, 2023 | 25.53% |
| Mar 31, 2023 | -103.08% |
| Dec 31, 2022 | -7.99% |
| Sep 30, 2022 | 41.04% |
| Jun 30, 2022 | 26.11% |
| Mar 31, 2022 | 44.74% |
| Dec 31, 2021 | 51.96% |
| Sep 30, 2021 | 59.16% |
| Jun 30, 2021 | 56.20% |
| Mar 31, 2021 | 48.25% |
| Dec 31, 2020 | 23.03% |